GSP Crop Science Publishes Q3FY26 Results with Corrected Financial Data
GSP Crop Science Limited published its Q3FY26 quarterly results in newspapers on April 13, 2026, reporting consolidated revenue of ₹2,703.50 million and improved net loss of ₹59.93 million. The company approved sale of industrial land to promoter group company for ₹2,365 lakhs and successfully completed its IPO raising ₹2,400 million with shares listed on NSE and BSE.

*this image is generated using AI for illustrative purposes only.
GSP Crop Science Limited announced its unaudited financial results for the third quarter and nine months ended December 31, 2025, during a board meeting held on April 11, 2026. The company also approved a significant asset transaction involving the sale of industrial land to a promoter group company. Subsequently, the company published its financial results extract in newspapers on April 13, 2026.
Q3FY26 Financial Performance
The company reported consolidated revenue from operations of ₹2,703.50 million for Q3FY26, compared to ₹2,759.38 million in the corresponding quarter of the previous year. For the nine-month period, consolidated revenue reached ₹11,146.41 million, representing growth from ₹9,793.94 million in the same period last year.
| Financial Metrics: | Q3FY26 | Q3FY25 | Change |
|---|---|---|---|
| Consolidated Revenue: | ₹2,703.50 million | ₹2,759.38 million | -2.02% |
| Standalone Revenue: | ₹2,766.42 million | ₹2,956.82 million | -6.44% |
| Nine-Month Consolidated Revenue: | ₹11,146.41 million | ₹9,793.94 million | +13.81% |
| Consolidated Net Loss (Q3): | ₹59.93 million | ₹62.36 million | Improved |
The company recorded a consolidated net loss of ₹59.93 million for Q3FY26, showing improvement from the ₹62.36 million loss in Q3FY25. However, for the nine-month period, the company achieved a consolidated net profit of ₹750.72 million compared to ₹596.33 million in the previous year.
Major Asset Sale Transaction
The board approved the sale of industrial land measuring 66,740.60 square meters to Indo GSP Chemicals Private Limited, a promoter group company, for a consideration of ₹2,365 lakhs. The company stated that this transaction enables efficient monetization of an unutilized asset while retaining adequate land for future expansion.
| Transaction Details: | Information |
|---|---|
| Land Area: | 66,740.60 square meters |
| Sale Consideration: | ₹2,365 lakhs |
| Buyer: | Indo GSP Chemicals Private Limited |
| Relationship: | Promoter Group Company |
Regulatory Compliance and Publication
Pursuant to Regulation 30 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, GSP Crop Science published the extract of its unaudited financial results in Business Standard newspaper in English and Jay Hind newspaper in Gujarati on April 13, 2026. The information is also available on the company's website at www.gspcrop.in .
| Publication Details: | Information |
|---|---|
| English Newspaper: | Business Standard |
| Gujarati Newspaper: | Jay Hind |
| Publication Date: | April 13, 2026 |
| Website: | www.gspcrop.in |
IPO Proceeds and Future Plans
Subsequent to the quarter ended December 31, 2025, GSP Crop Science completed its Initial Public Offering of 75,00,000 equity shares at ₹320 per share, with listing on NSE and BSE on March 24, 2026. The company received ₹2,400.00 million in escrow account from the fresh issue proceeds.
| IPO Utilization Plan: | Amount (₹ million) | Status |
|---|---|---|
| Debt Repayment: | 1,700.00 | Unutilized |
| General Corporate Purposes: | 700.00 | Unutilized |
The board meeting, which commenced at 4:25 PM and concluded at 5:30 PM, was conducted in compliance with SEBI regulations. Company Secretary Kamleshbhai D Patel signed the formal communication to stock exchanges, maintaining the company's commitment to regulatory transparency and corporate governance standards.
How will GSP Crop Science deploy the ₹2,400 million IPO proceeds for debt repayment and expansion, and what timeline has been set for utilization?
What impact will the land sale proceeds of ₹2,365 lakhs have on the company's capital allocation strategy and future growth investments?
Can GSP Crop Science sustain its nine-month revenue growth momentum of 13.81% despite the quarterly decline in Q3FY26?































